Trials / Unknown
UnknownNCT03256084
Tumoral Circulating Cells and Colorectal Cancer Progression
Characterization of Tumoral Circulating Cells According to Stage of Progression of Colorectal Cancers
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Institut Paoli-Calmettes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective research of circulating tumor cells as markers of progression risk in colorectal cancer.
Detailed description
This study aims at allowing a better understanding of which circulating tumor cells (CTC) have the higher risk of metastasis of in the overall population of CTC. Prospective monocenter open-label study. In the frame of the management of the disease, blood samples will be collected at different times of treatment, regarding disease status (localized of stage II/III, metastatic non resectable, metastatic potentially resectable). Tissue samples will be collected for patients scheduled for surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood and tumor samples | Blood and tumor samples |
Timeline
- Start date
- 2017-07-17
- Primary completion
- 2022-05-01
- Completion
- 2025-05-01
- First posted
- 2017-08-21
- Last updated
- 2021-05-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03256084. Inclusion in this directory is not an endorsement.